News for Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)

PR NewswireITASCA, Ill., Jan. 21, 2025 Expanding Partnerships with Major Industry PlayersITASCA, Ill., Jan. 21, 2025 /PRNewswire/ -- Lakeside Holding Limit

United States business ecosystem is expected to grow at a 5.4% CAGR, reaching USD 3,238.8 million by 2034, driven by rising obesity rates and demand for...

Increased awareness of the significance of nutrition in cancer therapy as a result of concerted efforts by advocacy groups, the government, and healthcare...

Sales Reflect Sustained Growth, Particularly in Oncology and Vaccines Total Worldwide Sales Were $16.0 Billion, an Increase of 7% From Third Quarter 2022; Excluding LAGEVRIO, Growth Was 6%;...

/PRNewswire/ -- The global intravenous (IV) solutions market size is estimated to increase by USD 4,011.34 million from 2022 to 2027. The market's growth...

/PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around...

/PRNewswire/ -- According to Arizton's latest research report, the global parenteral nutrition market will grow at a CAGR of 7% from 2021-2027. The rising...

Acumen Research and Consulting recently published report titled “Parenteral Nutrition Market Report and Region Forecast, 2022 - 2030”...

Merck & Co. Inc. undefined said Thursday that it entered into an agreement with Sichuan Kelun Pharmaceutical Co. Ltd. undefined to develop seven new cancer...

Merck , known as MSD outside of the United States and Canada, and Kelun-Biotech , a clinical-stage biotech company focused on biologic and small molecule discovery and development, today announced... | December 22, 2022